Etravirine in Treatment-Experienced, Hiv-1-Infected Children and Adolescents: 48-Week Safety, Efficacy and Resistance Analysis of the Phase Ii Piano Study
AuthID
P-00J-QMV
P-00J-QMV
© 2026 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service